Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2026-02-20 @ 3:43 AM
Study NCT ID:
NCT05223595
Status:
UNKNOWN
Last Update Posted:
2022-02-04
First Post:
2022-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Organization: